Quick answer
There is no confirmed UK price for orforglipron as of June 2026 — it has not received MHRA approval and no GPhC-registered provider has listed it. UK pricing will only be known at launch. For context, the Wegovy tablet (oral semaglutide) starts at £64/month. Speak to your prescriber about approved options.
Orforglipron price UK: what it could cost and how we will track it
No confirmed UK price for orforglipron exists as of June 2026. The drug has not received MHRA approval and no UK provider has listed a price. This page explains what price signals exist from other markets, how we will track it when it arrives, and how it might compare to the Wegovy tablet.
Current status: no UK price confirmed
Orforglipron is not approved or available in the UK. Any price quoted by a UK website today is speculative or, worse, from an unregulated source. We will not publish speculative pricing — only confirmed, verified prices from GPhC-registered providers.
What US pricing signals tell us
The United States typically sees first-to-market pricing for drugs before the UK. Eli Lilly has priced Mounjaro pens in the US at a list price significantly above UK market prices, though the real-world cost varies with insurance, programmes and pharmacy negotiation. For context, the Wegovy tablet launched in the UK at £64–£119 per first month across our tracked providers.
Small-molecule drugs (which orforglipron is) are generally cheaper to manufacture than peptide-based drugs. However, launch prices in specialist markets often reflect commercial strategy rather than manufacturing cost, particularly in the first 12–24 months after approval.
How orforglipron pricing might compare to the Wegovy tablet
| Factor | Wegovy tablet (current) | Orforglipron (estimated) |
|---|---|---|
| UK approval status | Approved, pre-order live | Not yet approved |
| Lowest UK visible start | £64/month (Juniper) | Not known |
| Fasting requirement | Yes — 30 mins before food | Potentially no |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Drug type | Peptide semaglutide | Small-molecule GLP-1 |
Will orforglipron be cheaper than the Wegovy tablet?
This is the question we hear most. The short answer: we do not know yet. Small-molecule manufacturing is typically lower-cost at scale, but UK launch prices are determined by negotiation, market positioning and NHS pricing frameworks — not manufacturing cost alone. Eli Lilly may price orforglipron to compete with the Wegovy tablet, or at a premium reflecting the no-fasting convenience benefit.
We will publish a verified price comparison the moment orforglipron is listed by any GPhC-registered UK provider.
How we will track orforglipron pricing
We track all 80+ UK providers weekly. Our methodology covers:
- Any new provider listing for oral GLP-1 drugs including orforglipron
- Pre-order prices as soon as they appear
- First-month vs ongoing pricing differences
- Discount codes and promotional offers
When orforglipron gets a UK listing, it will appear in our main provider tracker alongside the current Wegovy tablet providers.
Get notified when a UK price is confirmed
Leave your email below and we will alert you the moment a verified UK orforglipron price appears from a GPhC-registered provider. No speculation — only confirmed data.
Alert me when UK orforglipron pricing is confirmed →
Related pages
Frequently asked questions
How much will orforglipron cost in the UK?
No confirmed UK price exists yet — orforglipron is not MHRA-approved. Once a GPhC-registered provider lists it we will publish verified pricing. For now the Wegovy tablet starts at £64/month.
Is orforglipron cheaper than the Wegovy tablet?
Unknown. Small-molecule drugs can cost less to make, but UK launch prices reflect commercial strategy, not manufacturing cost. We will compare verified prices once orforglipron is listed.
Can I pre-order orforglipron in the UK?
No. No GPhC-registered UK provider can supply or pre-order orforglipron yet. Any site offering it is not operating as a regulated pharmacy.
When will a UK orforglipron price be confirmed?
Only after MHRA approval and a provider listing. We track UK providers weekly and will alert subscribers the moment a verified price appears.